Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,

Updated on: June 07,2024

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,

Updated on:June 07,2024

Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

by Atrium Health Wake Forest BaptistSenescent neurons are represented by areas of blue, red and white. Senescent cells are old, sick cells that cannot properly repair themselves and don't die

Updated on: March 02,2024

Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

by Atrium Health Wake Forest BaptistSenescent neurons are represented by areas of blue, red and white. Senescent cells are old, sick cells that cannot properly repair themselves and don't die

Updated on:March 02,2024

Professor discusses what's new in concussion treatment and management

by Laura Bailey,University of MichiganCredit: Unsplash/CC0 Public DomainThere have been significant changes in the last few years in how concussions are identified and treated. Steven Broglio, d

Updated on: March 30,2024

Professor discusses what's new in concussion treatment and management

by Laura Bailey,University of MichiganCredit: Unsplash/CC0 Public DomainThere have been significant changes in the last few years in how concussions are identified and treated. Steven Broglio, d

Updated on:March 30,2024

Study discovers possible tool to diagnose common contributor to vascular dementia

by Keck School of Medicine of USCOptical coherence tomography angiography (OCTA) images representative of high (top row), and low (bottom row) OCTA perfusion measures, and their corresponding FW

Updated on: March 02,2024

Study discovers possible tool to diagnose common contributor to vascular dementia

by Keck School of Medicine of USCOptical coherence tomography angiography (OCTA) images representative of high (top row), and low (bottom row) OCTA perfusion measures, and their corresponding FW

Updated on:March 02,2024

What an animated taco reveals about curiosity and patience

byDuke UniversityCredit: Pixabay/CC0 Public DomainCuriosity paradoxically increases people's patience for an answer, while simultaneously making them more eager to hear it, finds a new study

Updated on: January 12,2024

What an animated taco reveals about curiosity and patience

byDuke UniversityCredit: Pixabay/CC0 Public DomainCuriosity paradoxically increases people's patience for an answer, while simultaneously making them more eager to hear it, finds a new study

Updated on:January 12,2024

Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

by University of Eastern FinlandEnhanced lifestyle counselling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer's disease, accor

Updated on: March 07,2024

Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

by University of Eastern FinlandEnhanced lifestyle counselling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer's disease, accor

Updated on:March 07,2024

Recurrent brain trauma may increase Alzheimer's risk

by Radiological Society of North AmericaParametric maps of amyloid deposition in healthy control participants (A and B) and blast-exposed military instructors (C and D) at baseline (A and C) and

Updated on: June 01,2024

Recurrent brain trauma may increase Alzheimer's risk

by Radiological Society of North AmericaParametric maps of amyloid deposition in healthy control participants (A and B) and blast-exposed military instructors (C and D) at baseline (A and C) and

Updated on:June 01,2024

Study reveals brain's role in starting meals through GABA, dopamine

by Taylor Barnes,Baylor College of MedicineCredit:Metabolism(2024). DOI: 10.1016/j.metabol.2024.156099When you are feeling hungry, the brain takes the necessary steps toward consumin

Updated on: January 15,2025

Study reveals brain's role in starting meals through GABA, dopamine

by Taylor Barnes,Baylor College of MedicineCredit:Metabolism(2024). DOI: 10.1016/j.metabol.2024.156099When you are feeling hungry, the brain takes the necessary steps toward consumin

Updated on:January 15,2025

Dementia study reveals how toxic proteins spread through brain

by University of EdinburghGraphical Abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.04.020Fresh insights into the spread of damaging proteins that build up in the brains of

Updated on: February 03,2024

Dementia study reveals how toxic proteins spread through brain

by University of EdinburghGraphical Abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.04.020Fresh insights into the spread of damaging proteins that build up in the brains of

Updated on:February 03,2024

Hidden financial dimensions affect people with cognitive decline and their care partners, report says

by The Gerontological Society of AmericaCredit: CC0 Public DomainIn planning for older adulthood, many people both fear and consistently underestimate the risk of Alzheimer's disease and related d

Updated on: April 29,2024

Hidden financial dimensions affect people with cognitive decline and their care partners, report says

by The Gerontological Society of AmericaCredit: CC0 Public DomainIn planning for older adulthood, many people both fear and consistently underestimate the risk of Alzheimer's disease and related d

Updated on:April 29,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil

Updated on: May 22,2024

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil

Updated on:May 22,2024